|
private:nexstim
|
147230
|
May 30th, 2019 12:00AM
|
Nexstim
|
1.1K
|
39.00
|
Open
|
Medical Devices
|
May 30th, 2019 02:14PM
|
May 30th, 2019 02:14PM
|
Nexstim is the world leader in image-guided transcranial magnetic stimulation (TMS)
Founded in 2000 in Helsinki, Finland, Nexstim is committed to improving the quality of life of patients with significant unmet clinical needs. We have developed a world-leading SmartFocus TMS technology, a non-invasive brain stimulation system for the treatment of Major Depressive Disorder (MDD). Our system, with the highly sophisticated 3D navigation, is the only personalised, navigated transcranial magnetic stimulation (TMS) approach providing accurate targeting of the TMS to the specific area of the brain associated with MDD.
Nexstim’s NBT® system has been launched in the US for the treatment of MDD following clearance from the FDA for marketing and commercial distribution for this indication. The NBT® system is CE marked in Europe for the treatment of major depression and chronic neuropathic pain.
In addition, we have a pioneered the technology for brain diagnostics and we hold the only FDA-clearances for non-invasive pre-surgical mapping with the Navigated Brain Stimulation (NBS) System for the primary motor cortex and NexSpeech® for speech and language function. NBS is recognized as the emerging standard for pre-operative direct functional mapping. Our NBS system is the only FDA cleared and CE marked navigated TMS system for pre-surgical mapping of the speech and motor cortices of the brain.
Nexstim shares are listed on the Nasdaq First North Finland and Nasdaq First North Sweden.
|
Open
|
TMS, nTMS, Brain Mapping, Transcranial Magnetic Stimulation
|
Open
|
Elimäenkatu 9 B
|
Helsinki
|
|
FI
|
FI-00510
|
|
Nexstim
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
private:nexstim
|
147230
|
Feb 17th, 2018 12:00AM
|
Nexstim
|
705
|
32.00
|
Open
|
Medical Devices
|
Feb 17th, 2018 02:25PM
|
Feb 17th, 2018 02:25PM
|
Nexstim is the world leader in image-guided transcranial magnetic stimulation (TMS)
Founded in 2000 in Helsinki, Finland, Nexstim is committed to improving the quality of life of patients with significant unmet clinical needs by helping to preserve what is vital. Nexstim has pioneered the technology for brain diagnostics and holds the only FDA-clearances for non-invasive pre-surgical mapping with the Navigated Brain Stimulation (NBS) System for the primary motor cortex and NexSpeech® for speech and language function. NBS is recognized as the emerging standard for pre-operative direct functional mapping.
NBS Makes TMS Visible
Nexstim’s technology introduces navigated transcranial magnetic stimulation (nTMS) for pre-surgical non-invasive mapping. The navigation is based on the patient´s MRI scan and proprietary electric field modeling, allowing the NBS System to uniquely show the location and orientation of TMS-stimuli inside the brain. NBS and NexSpeech® accurately and reliably maps the brain's vital functions like a GPS maps the globe. Nexstim offers a comfortable and safe method for brain mapping in adults or children with a diagnosis of tumor or epilepsy.
The Difference is Accuracy
The NBS System is as accurate as the "gold standard" of intraoperative direct cortical stimulation (DCS). Multiple papers have shown that Nexstim’s NBS mappings are more accurate than fMRI and MEG. Mapping results may enable more patients to be offered a surgical option, and eliminate surgical candidates before they go into the OR. NBS data leads to better planning for a more complete tumor resection, offering smaller craniotomies and less time in the OR. Better planning leads to decreasing the risk of damage to the eloquent cortex, thereby preserving a patient’s vital function.
|
|
|
|
|
|
|
|
|
|
Nexstim
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
private:nexstim
|
147230
|
Feb 16th, 2018 12:00AM
|
Nexstim
|
705
|
32.00
|
Open
|
Medical Devices
|
Feb 16th, 2017 08:15AM
|
Feb 16th, 2017 08:15AM
|
Nexstim is the world leader in image-guided transcranial magnetic stimulation (TMS)
Founded in 2000 in Helsinki, Finland, Nexstim is committed to improving the quality of life of patients with significant unmet clinical needs by helping to preserve what is vital. Nexstim has pioneered the technology for brain diagnostics and holds the only FDA-clearances for non-invasive pre-surgical mapping with the Navigated Brain Stimulation (NBS) System for the primary motor cortex and NexSpeech® for speech and language function. NBS is recognized as the emerging standard for pre-operative direct functional mapping.
NBS Makes TMS Visible
Nexstim’s technology introduces navigated transcranial magnetic stimulation (nTMS) for pre-surgical non-invasive mapping. The navigation is based on the patient´s MRI scan and proprietary electric field modeling, allowing the NBS System to uniquely show the location and orientation of TMS-stimuli inside the brain. NBS and NexSpeech® accurately and reliably maps the brain's vital functions like a GPS maps the globe. Nexstim offers a comfortable and safe method for brain mapping in adults or children with a diagnosis of tumor or epilepsy.
The Difference is Accuracy
The NBS System is as accurate as the "gold standard" of intraoperative direct cortical stimulation (DCS). Multiple papers have shown that Nexstim’s NBS mappings are more accurate than fMRI and MEG. Mapping results may enable more patients to be offered a surgical option, and eliminate surgical candidates before they go into the OR. NBS data leads to better planning for a more complete tumor resection, offering smaller craniotomies and less time in the OR. Better planning leads to decreasing the risk of damage to the eloquent cortex, thereby preserving a patient’s vital function.
|
|
|
|
|
|
|
|
|
|
Nexstim
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
private:nexstim
|
147230
|
Feb 15th, 2018 12:00AM
|
Nexstim
|
705
|
32.00
|
Open
|
Medical Devices
|
Feb 15th, 2017 10:07AM
|
Feb 15th, 2017 10:07AM
|
Nexstim is the world leader in image-guided transcranial magnetic stimulation (TMS)
Founded in 2000 in Helsinki, Finland, Nexstim is committed to improving the quality of life of patients with significant unmet clinical needs by helping to preserve what is vital. Nexstim has pioneered the technology for brain diagnostics and holds the only FDA-clearances for non-invasive pre-surgical mapping with the Navigated Brain Stimulation (NBS) System for the primary motor cortex and NexSpeech® for speech and language function. NBS is recognized as the emerging standard for pre-operative direct functional mapping.
NBS Makes TMS Visible
Nexstim’s technology introduces navigated transcranial magnetic stimulation (nTMS) for pre-surgical non-invasive mapping. The navigation is based on the patient´s MRI scan and proprietary electric field modeling, allowing the NBS System to uniquely show the location and orientation of TMS-stimuli inside the brain. NBS and NexSpeech® accurately and reliably maps the brain's vital functions like a GPS maps the globe. Nexstim offers a comfortable and safe method for brain mapping in adults or children with a diagnosis of tumor or epilepsy.
The Difference is Accuracy
The NBS System is as accurate as the "gold standard" of intraoperative direct cortical stimulation (DCS). Multiple papers have shown that Nexstim’s NBS mappings are more accurate than fMRI and MEG. Mapping results may enable more patients to be offered a surgical option, and eliminate surgical candidates before they go into the OR. NBS data leads to better planning for a more complete tumor resection, offering smaller craniotomies and less time in the OR. Better planning leads to decreasing the risk of damage to the eloquent cortex, thereby preserving a patient’s vital function.
|
|
|
|
|
|
|
|
|
|
Nexstim
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
private:nexstim
|
147230
|
Feb 14th, 2018 12:00AM
|
Nexstim
|
705
|
32.00
|
Open
|
Medical Devices
|
Feb 14th, 2017 01:50PM
|
Feb 14th, 2017 01:50PM
|
Nexstim is the world leader in image-guided transcranial magnetic stimulation (TMS)
Founded in 2000 in Helsinki, Finland, Nexstim is committed to improving the quality of life of patients with significant unmet clinical needs by helping to preserve what is vital. Nexstim has pioneered the technology for brain diagnostics and holds the only FDA-clearances for non-invasive pre-surgical mapping with the Navigated Brain Stimulation (NBS) System for the primary motor cortex and NexSpeech® for speech and language function. NBS is recognized as the emerging standard for pre-operative direct functional mapping.
NBS Makes TMS Visible
Nexstim’s technology introduces navigated transcranial magnetic stimulation (nTMS) for pre-surgical non-invasive mapping. The navigation is based on the patient´s MRI scan and proprietary electric field modeling, allowing the NBS System to uniquely show the location and orientation of TMS-stimuli inside the brain. NBS and NexSpeech® accurately and reliably maps the brain's vital functions like a GPS maps the globe. Nexstim offers a comfortable and safe method for brain mapping in adults or children with a diagnosis of tumor or epilepsy.
The Difference is Accuracy
The NBS System is as accurate as the "gold standard" of intraoperative direct cortical stimulation (DCS). Multiple papers have shown that Nexstim’s NBS mappings are more accurate than fMRI and MEG. Mapping results may enable more patients to be offered a surgical option, and eliminate surgical candidates before they go into the OR. NBS data leads to better planning for a more complete tumor resection, offering smaller craniotomies and less time in the OR. Better planning leads to decreasing the risk of damage to the eloquent cortex, thereby preserving a patient’s vital function.
|
|
|
|
|
|
|
|
|
|
Nexstim
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
private:nexstim
|
147230
|
Feb 13th, 2018 12:00AM
|
Nexstim
|
705
|
32.00
|
Open
|
Medical Devices
|
Feb 13th, 2017 04:11PM
|
Feb 13th, 2017 04:11PM
|
Nexstim is the world leader in image-guided transcranial magnetic stimulation (TMS)
Founded in 2000 in Helsinki, Finland, Nexstim is committed to improving the quality of life of patients with significant unmet clinical needs by helping to preserve what is vital. Nexstim has pioneered the technology for brain diagnostics and holds the only FDA-clearances for non-invasive pre-surgical mapping with the Navigated Brain Stimulation (NBS) System for the primary motor cortex and NexSpeech® for speech and language function. NBS is recognized as the emerging standard for pre-operative direct functional mapping.
NBS Makes TMS Visible
Nexstim’s technology introduces navigated transcranial magnetic stimulation (nTMS) for pre-surgical non-invasive mapping. The navigation is based on the patient´s MRI scan and proprietary electric field modeling, allowing the NBS System to uniquely show the location and orientation of TMS-stimuli inside the brain. NBS and NexSpeech® accurately and reliably maps the brain's vital functions like a GPS maps the globe. Nexstim offers a comfortable and safe method for brain mapping in adults or children with a diagnosis of tumor or epilepsy.
The Difference is Accuracy
The NBS System is as accurate as the "gold standard" of intraoperative direct cortical stimulation (DCS). Multiple papers have shown that Nexstim’s NBS mappings are more accurate than fMRI and MEG. Mapping results may enable more patients to be offered a surgical option, and eliminate surgical candidates before they go into the OR. NBS data leads to better planning for a more complete tumor resection, offering smaller craniotomies and less time in the OR. Better planning leads to decreasing the risk of damage to the eloquent cortex, thereby preserving a patient’s vital function.
|
|
|
|
|
|
|
|
|
|
Nexstim
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
private:nexstim
|
147230
|
Feb 12th, 2018 12:00AM
|
Nexstim
|
705
|
32.00
|
Open
|
Medical Devices
|
Feb 12th, 2017 04:15AM
|
Feb 12th, 2017 04:15AM
|
Nexstim is the world leader in image-guided transcranial magnetic stimulation (TMS)
Founded in 2000 in Helsinki, Finland, Nexstim is committed to improving the quality of life of patients with significant unmet clinical needs by helping to preserve what is vital. Nexstim has pioneered the technology for brain diagnostics and holds the only FDA-clearances for non-invasive pre-surgical mapping with the Navigated Brain Stimulation (NBS) System for the primary motor cortex and NexSpeech® for speech and language function. NBS is recognized as the emerging standard for pre-operative direct functional mapping.
NBS Makes TMS Visible
Nexstim’s technology introduces navigated transcranial magnetic stimulation (nTMS) for pre-surgical non-invasive mapping. The navigation is based on the patient´s MRI scan and proprietary electric field modeling, allowing the NBS System to uniquely show the location and orientation of TMS-stimuli inside the brain. NBS and NexSpeech® accurately and reliably maps the brain's vital functions like a GPS maps the globe. Nexstim offers a comfortable and safe method for brain mapping in adults or children with a diagnosis of tumor or epilepsy.
The Difference is Accuracy
The NBS System is as accurate as the "gold standard" of intraoperative direct cortical stimulation (DCS). Multiple papers have shown that Nexstim’s NBS mappings are more accurate than fMRI and MEG. Mapping results may enable more patients to be offered a surgical option, and eliminate surgical candidates before they go into the OR. NBS data leads to better planning for a more complete tumor resection, offering smaller craniotomies and less time in the OR. Better planning leads to decreasing the risk of damage to the eloquent cortex, thereby preserving a patient’s vital function.
|
|
|
|
|
|
|
|
|
|
Nexstim
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
private:nexstim
|
147230
|
Feb 11th, 2018 12:00AM
|
Nexstim
|
705
|
32.00
|
Open
|
Medical Devices
|
Feb 11th, 2017 05:35AM
|
Feb 11th, 2017 05:35AM
|
Nexstim is the world leader in image-guided transcranial magnetic stimulation (TMS)
Founded in 2000 in Helsinki, Finland, Nexstim is committed to improving the quality of life of patients with significant unmet clinical needs by helping to preserve what is vital. Nexstim has pioneered the technology for brain diagnostics and holds the only FDA-clearances for non-invasive pre-surgical mapping with the Navigated Brain Stimulation (NBS) System for the primary motor cortex and NexSpeech® for speech and language function. NBS is recognized as the emerging standard for pre-operative direct functional mapping.
NBS Makes TMS Visible
Nexstim’s technology introduces navigated transcranial magnetic stimulation (nTMS) for pre-surgical non-invasive mapping. The navigation is based on the patient´s MRI scan and proprietary electric field modeling, allowing the NBS System to uniquely show the location and orientation of TMS-stimuli inside the brain. NBS and NexSpeech® accurately and reliably maps the brain's vital functions like a GPS maps the globe. Nexstim offers a comfortable and safe method for brain mapping in adults or children with a diagnosis of tumor or epilepsy.
The Difference is Accuracy
The NBS System is as accurate as the "gold standard" of intraoperative direct cortical stimulation (DCS). Multiple papers have shown that Nexstim’s NBS mappings are more accurate than fMRI and MEG. Mapping results may enable more patients to be offered a surgical option, and eliminate surgical candidates before they go into the OR. NBS data leads to better planning for a more complete tumor resection, offering smaller craniotomies and less time in the OR. Better planning leads to decreasing the risk of damage to the eloquent cortex, thereby preserving a patient’s vital function.
|
|
|
|
|
|
|
|
|
|
Nexstim
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
private:nexstim
|
147230
|
Feb 10th, 2018 12:00AM
|
Nexstim
|
705
|
32.00
|
Open
|
Medical Devices
|
Feb 10th, 2017 06:43AM
|
Feb 10th, 2017 06:43AM
|
Nexstim is the world leader in image-guided transcranial magnetic stimulation (TMS)
Founded in 2000 in Helsinki, Finland, Nexstim is committed to improving the quality of life of patients with significant unmet clinical needs by helping to preserve what is vital. Nexstim has pioneered the technology for brain diagnostics and holds the only FDA-clearances for non-invasive pre-surgical mapping with the Navigated Brain Stimulation (NBS) System for the primary motor cortex and NexSpeech® for speech and language function. NBS is recognized as the emerging standard for pre-operative direct functional mapping.
NBS Makes TMS Visible
Nexstim’s technology introduces navigated transcranial magnetic stimulation (nTMS) for pre-surgical non-invasive mapping. The navigation is based on the patient´s MRI scan and proprietary electric field modeling, allowing the NBS System to uniquely show the location and orientation of TMS-stimuli inside the brain. NBS and NexSpeech® accurately and reliably maps the brain's vital functions like a GPS maps the globe. Nexstim offers a comfortable and safe method for brain mapping in adults or children with a diagnosis of tumor or epilepsy.
The Difference is Accuracy
The NBS System is as accurate as the "gold standard" of intraoperative direct cortical stimulation (DCS). Multiple papers have shown that Nexstim’s NBS mappings are more accurate than fMRI and MEG. Mapping results may enable more patients to be offered a surgical option, and eliminate surgical candidates before they go into the OR. NBS data leads to better planning for a more complete tumor resection, offering smaller craniotomies and less time in the OR. Better planning leads to decreasing the risk of damage to the eloquent cortex, thereby preserving a patient’s vital function.
|
|
|
|
|
|
|
|
|
|
Nexstim
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
private:nexstim
|
147230
|
Feb 9th, 2018 12:00AM
|
Nexstim
|
705
|
32.00
|
Open
|
Medical Devices
|
Feb 9th, 2017 08:57AM
|
Feb 9th, 2017 08:57AM
|
Nexstim is the world leader in image-guided transcranial magnetic stimulation (TMS)
Founded in 2000 in Helsinki, Finland, Nexstim is committed to improving the quality of life of patients with significant unmet clinical needs by helping to preserve what is vital. Nexstim has pioneered the technology for brain diagnostics and holds the only FDA-clearances for non-invasive pre-surgical mapping with the Navigated Brain Stimulation (NBS) System for the primary motor cortex and NexSpeech® for speech and language function. NBS is recognized as the emerging standard for pre-operative direct functional mapping.
NBS Makes TMS Visible
Nexstim’s technology introduces navigated transcranial magnetic stimulation (nTMS) for pre-surgical non-invasive mapping. The navigation is based on the patient´s MRI scan and proprietary electric field modeling, allowing the NBS System to uniquely show the location and orientation of TMS-stimuli inside the brain. NBS and NexSpeech® accurately and reliably maps the brain's vital functions like a GPS maps the globe. Nexstim offers a comfortable and safe method for brain mapping in adults or children with a diagnosis of tumor or epilepsy.
The Difference is Accuracy
The NBS System is as accurate as the "gold standard" of intraoperative direct cortical stimulation (DCS). Multiple papers have shown that Nexstim’s NBS mappings are more accurate than fMRI and MEG. Mapping results may enable more patients to be offered a surgical option, and eliminate surgical candidates before they go into the OR. NBS data leads to better planning for a more complete tumor resection, offering smaller craniotomies and less time in the OR. Better planning leads to decreasing the risk of damage to the eloquent cortex, thereby preserving a patient’s vital function.
|
|
|
|
|
|
|
|
|
|
Nexstim
|
Health Care
|
Pharmaceuticals & Biotechnology
|